Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 nov. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Third Quarter 2012 Financial Results and Business Update

NEWARK, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
30 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Partners With R Biomedical to Develop and Commercialize Reagents for Human iPS Cell Research

NEWARK, Calif., Oct. 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has partnered with R Biomedical, an Edinburgh, UK-based biomedical company, to develop and...
26 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. to Present at 2012 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

NEWARK, Calif., Oct. 26, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
18 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Adds Eliseo Salinas to Advise on Product Development Strategy for Its Proprietary Human Neural Stem Cells

NEWARK, Calif., Oct. 18, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced it has retained Eliseo Oreste Salinas, MD, MSc, on an exclusive basis, to help formulate and execute the...
17 oct. 2012 09h00 HE | Source: StemCells, Inc.

Ascendiant Capital Markets Initiates Research Coverage of StemCells, Inc. With Buy Recommendation

NEWARK, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ascendiant Capital Markets, LLC initiated independent research coverage on the Company with a "Buy"...
16 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Launches Four New Human Neural Stem Cell Kits Under SC Proven(R) Brand

NEWARK, Calif., Oct. 16, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of four new SC Proven human neural stem cell (NSC) kits for use in neuroscience research....
12 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Awarded Broad U.S. Patent Covering Expandable Liver Cells

NEWARK, Calif., Oct. 12, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the issuance of U.S. Patent Number 8,283,164 titled "Liver engrafting cells, assays, and uses thereof."...
10 oct. 2012 14h00 HE | Source: StemCells, Inc.

StemCells, Inc. Announces Simultaneous Publication of Preclinical and Clinical Results of Its Neural Stem Cells for Myelination Disorder

NEWARK, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that two papers reporting clinical and preclinical data demonstrating the therapeutic potential of the...
04 oct. 2012 09h00 HE | Source: StemCells, Inc.

StemCells, Inc. Announces First Transplant of Neural Stem Cells Into Patient in Clinical Trial for Dry Age-Related Macular Degeneration

NEWARK, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the first patient in its Phase I/II clinical trial in dry age-related macular degeneration (AMD) has...
27 sept. 2012 09h52 HE | Source: StemCells, Inc.

StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury

NEWARK, Calif., Sept. 27, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the first patient with an incomplete spinal cord injury has been enrolled in the Company's Phase...

Page précédente